NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
81 hedge funds and large institutions have $73.3M invested in Navidea Biopharmaceuticals Inc. in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
99% less call options, than puts
Call options by funds: $59K | Put options by funds: $8.6M
Holders
81
Holding in Top 10
1
Calls
$59K
Puts
$8.6M
Top Buyers
| 1 | +$1.59M | |
| 2 | +$244K | |
| 3 | +$173K | |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
+$172K |
| 5 |
Bank of New York Mellon
New York
|
+$139K |
Top Sellers
| 1 | -$1.75M | |
| 2 | -$218K | |
| 3 | -$161K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$156K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$124K |